What is the management of malaria in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Malaria in Children

Manage malaria in children using a structured ABC approach with immediate risk stratification, followed by intravenous quinine (20 mg/kg loading dose over 4 hours) for severe cases and supportive care targeting respiratory failure, shock, and neurological complications as the primary life-threatening emergencies. 1

Initial Assessment and Risk Stratification

The management of malaria in children begins with rapid triage assessment focusing on airway, breathing, and circulation before confirming diagnosis, as most deaths occur within hours of admission due to unrecognized circulatory collapse or respiratory compromise. 1

High-Risk Features Requiring Urgent Intervention

Children with any of the following require immediate supportive treatment: 1

  • Depressed conscious level (any degree) 1
  • Active seizure activity or status epilepticus 1
  • Respiratory compromise: irregular respirations, obstructed airway (pooling saliva/vomit), or hypoxia (oxygen saturations < 95%) 1
  • Shock indicators: systolic BP < 80 mm Hg (< 70 mm Hg if < 1 year) OR two or more of: tachycardia, increased work of breathing, cool peripheries, capillary refill time ≥ 3 seconds 1
  • Hypoglycemia < 3 mmol/l 1
  • Metabolic acidosis (base deficit > 8 mmol/l) 1
  • Severe hyperkalaemia (potassium > 5.5 mmol/l) 1

Intermediate-Risk Features

These children require high dependency care: 1

  • Hemoglobin < 100 g/l 1
  • History of convulsions during illness 1
  • Hyperparasitemia > 5% 1
  • Visible jaundice 1
  • Plasmodium falciparum in a child with sickle cell disease 1

Emergency Management Algorithm

Step 1: Airway and Breathing

Immediately assess and secure airway, as irregular breathing or drooling indicates complex seizures with respiratory depression. 1

  • Provide high-flow oxygen (10 L/min) if oxygen saturations < 95% 1
  • Monitor for characteristic respiratory patterns of severe malaria 1
  • Consider rapid sequence intubation if respiratory failure develops 1

Step 2: Circulation and Shock Management

Insert two large intravenous cannulae and assess for shock using pulse rate, capillary refill, temperature gradient, and blood pressure. 1

For children with shock: 1

  • First bolus: 20 ml/kg of colloid or 0.9% saline (or 20 ml/kg of 4.5% albumin if child in coma) 1
  • Observe closely for response/deterioration 1
  • If no response: repeat 20 ml/kg bolus 1
  • After 40 ml/kg with persistent shock: proceed to rapid sequence intubation and use central venous pressure monitoring to guide further fluid management 1

Critical caveat: Use cautious volume resuscitation in children presenting in coma due to risk of raised intracranial pressure. 1

Step 3: Neurological Assessment

After addressing airway, breathing, and circulation, assess conscious level and exclude: 1

  • Ongoing seizures 1
  • Hypoglycemia 1
  • Shock 1

If neurological deterioration occurs despite correction of above, consider raised intracranial pressure. 1

Antimalarial Treatment

Severe Malaria

Initiate intravenous quinine dihydrochloride immediately after initial resuscitation, even if awaiting diagnostic confirmation when clinical suspicion is high. 1

  • Loading dose: 20 mg/kg diluted in 20-40 ml, infused over 4 hours 1
  • Emergency management should not be delayed while awaiting malaria diagnosis confirmation 1
  • Specific antimalarial drugs can be deferred until resuscitation treatments are given and diagnosis confirmed, unless undue delay is likely 1

Uncomplicated Malaria

For children able to take oral medication: 1

  • Admit and observe on oral treatment 1
  • Never prescribe oral quinine (tablets or syrup) for young children, as it is unpalatable and compliance will be poor 1

Diagnostic Approach

Obtain thick and thin blood films from EDTA sample with direct laboratory liaison for urgent processing. 1

  • Three negative thick blood films taken 12 hours apart generally exclude malaria 1
  • Continue further films if clinical suspicion remains high 1
  • Rapid diagnostic tests (e.g., OptiMAL assay) have advantages in children with low-density parasitemia or those who have taken prophylaxis 1

Monitoring and Supportive Care

Check blood glucose immediately and serially, as hypoglycemia is a common life-threatening complication. 1

Take blood for: 1

  • Complete blood count 1
  • Metabolic panel (assess acidosis, electrolytes, renal function) 1
  • Blood glucose 1

Common Pitfalls to Avoid

Do not use experimental treatments such as exchange transfusion in initial management, as they distract from urgent, simple life-saving interventions. 1

Do not delay emergency management while awaiting diagnostic confirmation. 1

Do not miss impending circulatory collapse or respiratory compromise, which are the principal causes of death within hours of admission. 1

Do not overlook prolonged seizures as a cause of respiratory compromise. 1

Do not prescribe oral medications for children who are vomiting or unable to comply with oral medication. 1

Clinical Presentation Recognition

Consider malaria in any febrile child with travel history to endemic areas, even up to one year after exposure (particularly P. vivax, P. ovale, P. malariae). 1

Initial symptoms are non-specific: 1

  • Fever, cough, headache, malaise, vomiting, diarrhea 1
  • Splenomegaly, thrombocytopenia, anemia, mild jaundice may be absent in early stages 1

Urgent referral is mandatory for presumptive malaria diagnosis, as failure to expedite appropriate referral leads to life-threatening disease. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the role of Total Leukocyte Count (TLC) and Differential Leukocyte Count (DLC) in the management of malaria?
What blood tests confirm malaria reactivation?
Can malaria be diagnosed on the first day of fever?
What are the clinical features of malaria (Plasmodium infection)?
What is the most appropriate management for a patient presenting with cyclic fever, rigors, and sweating, with a blood film confirming malaria diagnosis?
For a patient on a basal-bolus insulin regimen, does the pre-lunch glucose level depend on basal insulin, prandial insulin given at breakfast, or both, and does the pre-dinner glucose level depend on basal insulin, prandial insulin given at lunch, or both?
Why are calcium channel blockers (CCBs) preferred over thiazide diuretics in patients with hypertension, particularly those with risk factors for diabetes, such as obesity and family history of diabetes?
What is the recommended approach for treating a patient with leukocytoclastic vasculitis and a history of hepatitis B (HBV) infection prior to initiating steroid therapy, considering the risk of HBV reactivation?
When should a patient with gout and recurrent gout attacks, joint damage, or kidney stones due to hyperuricemia start urate-lowering therapy, such as xanthine oxidase inhibitors (XOI) like allopurinol or febuxostat?
Is Tenofovir alafenamide (tenofovir alafenamide) effective for treating leukocytoclastic vasculitis, particularly in a patient with a history of HIV?
What is the target post-meal glucose level for a patient on a basal-bolus insulin regimen, and how should the prandial insulin dose be adjusted to achieve optimal glucose control?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.